Politico September 18, 2024
By Ben Leonard and Chelsea Cirruzzo

With Lauren Gardner and Daniel Payne

Driving the Day

READING THE PHARMA TEA LEAVES — Democratic presidential candidate Kamala Harris is launching several health care events with providers, advocates and lawmakers in swing states this week, signaling the issue will continue to be a major part of her campaign.

As California attorney general, Harris focused on health care — including challenging drug patent holders and unfair practices in marketing treatments for off-label use.

She’s now leaning into speeding up government drug pricing negotiations to reduce costs to Medicare beneficiaries and has previously supported “march-in” rights, when the government can lower prices by awarding a patent for research it funded to another company. Such measures signal an aggressive stance on drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Who Wins If The New Biden AI Export Rules Stand?
Federal Policy Debates in 2025 Carry High Stakes
Biden Issues Executive Order Governing AI Infrastructure
Biden opens federal land for AI data centers, sets rules for developers
STAT+: Former Trump FDA, CMS heads lay out how his return could reshape health policy

Share This Article